Effects of intrarenal administration of the calcium antagonist nimodipine during porcine aortic occlusion-induced ischemia/reperfusion injury

Shock

Volumn 29, Issue 6, 2008, Pages 717-723

  Fröba, Gebhard ^a   Bracht, Hendrik ^a   Hauser, Balázs ^a,b   Chkhouta, Archil B ^a,c   Huber Lang, Markus ^a   Rittirsch, Daniel ^a   Brückner, Uwe B ^a   Radermacher, Peter ^a   Schelzig, Hubert ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c A Tsulukidze National Centre of Urology   (Georgia)

Author keywords

Apoptosis; Ca2+ antagonist intra arterial drug perfusion; CDKI p21 gene expression; I R; Kidney function; TUNEL assay

Indexed keywords

BIOTIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; EOSIN; HEMATOXYLIN; LACTIC ACID; NIMODIPINE; PYRUVIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA OCCLUSION; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; ISCHEMIA; KIDNEY BLOOD FLOW; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY TUBULE DAMAGE; METABOLISM; NICK END LABELING; NONHUMAN; OXYGEN TRANSPORT; PROSPECTIVE STUDY; RENAL ARTERY; REPERFUSION; REPERFUSION INJURY; SWINE; URINE OSMOLALITY;

ANIMALS; AORTA; APOPTOSIS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; IN SITU NICK-END LABELING; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; NIMODIPINE; REPERFUSION INJURY; SWINE;

EID: 44449154213     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318160d6f9     Document Type: Article

References (40)

1. Gelman S: The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 182:1026-1060, 1995.
2. Sasaki T, Ohsawa S, Ogawa M, Mukaida M, Nakajima T, Komoda K, Tachieda R, Niinuma H, Kawazoe K: Postoperative renal function after an abdominal aortic aneurysm repair requiring a suprarenal aortic cross-clamp. Surg Today 30:33-36, 2000.
3. Lien YH, Lai LW, Silva AL: Pathogenesis of renal ischemia/reperfusion injury: lessons from knockout mice. Life Sci 74:543-552, 2003.
4. Schrier RW, Arnold PE, Van Putten VJ, Burke TJ: Cellular calcium in ischemic acute renal failure: role of calcium entry blockers. Kidney Int 32:313-321, 1987.
5. Humes HD: Role of calcium in pathogenesis of acute renal failure. Am J Physiol 250:F579-F589, 1986.
6. Paller MS, Greene EL: Role of calcium in reperfusion injury of the kidney. Ann N Y Acad Sci 723:59-70, 1994.
7. Tanaka T, Nangaku M, Miyata T, Inagi R, Ohse T, Ingelfinger JR, Fujita T: Blockade of calcium influx through L-type calcium channels attenuates mitochondrial injury and apoptosis in hypoxic renal tubular cells. J Am Soc Nephrol 15:2320-2333, 2004.
8. Malis CD, Bonventre JV: Mechanism of calcium potentiation of oxygen free radical injury to renal mitochondria. A model for post-ischemic and toxic mitochondrial damage. J Biol Chem 261:14201-14208, 1986.
9. Burke TJ, Arnold PE, Gordon JA, Bulger RE, Dobyan DC, Schrier RW: Protective effect of intrarenal calcium membrane blockers before or after renal ischemia. Functional, morphological, and mitochondrial studies. J Clin Invest 74:1830-1841, 1984.
10. Woolley JL, Barker GR, Jacobsen WK, Gingrich GA, Stewart SC, Briggs BA, Martin RD, Melashenko RA: Effect of the calcium entry blocker verapamil on renal ischemia. Crit Care Med 16:48-51,1988.
11. Sandin R, Feuk U, Wahlberg J, Modig J: Effects of diltiazem on postischaemic renal cortical microcirculation in the pig. Acta Anaesthesiol Scand 35:424-429, 1991.
12. Fröhlich ED: Calcium antagonists. Their physiological differences. Am J Hypertens 4:430S-433S, 1991.
13. Godin DV, Garnett ME: Species-related variations in tissue antioxidant status - I. Differences in antioxidant enzyme profiles. Comp Biochem Physiol B 103:737-742, 1992.
14. Godin DV, Garnett ME: Species-related variations in tissue antioxidant status - I. Differences in susceptibility to oxidative challenge. Comp Biochem Physiol B 103:743-748, 1992.
15. Hauser B, Fröba G, Bracht H, Sträter J, Chkhouta AB, Vassilev D, Schoaff MJ, Huber-Lang M, Brückner UB, Radermacher P, et al.: Effects of intrarenal administration of the COX-2 inhibitor parecoxib during porcine suprarenal aortic cross-clamping. Shock 24:476-481, 2005.
16. Mrak RE, Carry MM, Murphy ML, Peng CF, Straub KD: Reperfusion injury in ischemic myocardium: effects of nifedipine and verapamil. Am J Cardiovasc Pathol 3:61-68, 1990.
17. Uchida M, Takemoto Y, Nagasue N, Dhar DK, Kohno H, Nakamura T: Effect of verapamil on hepatic reperfusion injury after prolonged ischemia in pigs. J Hepatol 21:217-223, 1994.
18. Raju TN, John E, Shankararao R, Fornell L, Vasa R, Abu-Harb M: Effect of nimodipine on systemic, renal, and cerebral haemodynamics after a mild hypoxic-ischaemic insult in newborn piglets. Pharmacol Res 33:5-12, 1996.
19. Pittner A, Nalos M, Asfar P, Yang Y, Ince C, Georgieff M, Brückner UB, Radermacher P, Fröba G: Mechanisms of inducible nitric oxide synthase (iNOS) inhibition-related improvement of gut mucosal acidosis during hyperdynamic porcine endotoxemia. Intensive Care Med 29:312-316, 2003.
20. Chkhotua AB, Abendroth D, Froeba G, Schelzig H: Up-regulation of cell cycle regulatory genes after renal ischemia/reperfusion: differential expression of p16(INK4a), p21(WAF1/CIP1) and p27(Kip1) cyclin-dependent kinase inhibitor genes depending on reperfusion time. Transpl Int 19:72-77, 2006.
21. Kick J, Hauser B, Bracht H, Albicini M, Öter S, Simon F, Ehrmann U, Garrel C, Sträter J, Brückner UB, et al.: Effects of a cantaloupe melon extract/wheat gliadin biopolymer during aortic cross-clamping. Intensive Care Med 33:694-702, 2007.
22. Hauser B, Gröger M, Ehrmann U, Albicini M, Brückner UB, Schelzig H, Venkatesh B, Li H, Szabó C, Speit G, et al.: The PARP-1 inhibitor INO-1001 facilitates hemodynamic stabilization without affecting DNA repair in porcine thoracic aortic cross-clamping-induced ischemia/reperfusion. Shock 25:633-640, 2006.
23. Duncker DJ, Heiligers J, Mylecharane EJ, Saxena PR, Verdouw PD: Nimodipine-induced changes in the distribution of carotid blood flow and cardiac output in pentobarbitone-anaesthetized pigs. Br J Pharmacol 89:35-46, 1986.
24. Miller Q, Peyton BD, Cohn EJ, Holmes GF, Harlin SA, Bird ET, Harre JG, Miller ML, Riley KD, Hogan MB, et al.: The effects of intraoperative fenoldopam on renal blood flow and tubular function following suprarenal aortic cross-clamping. Ann Vasc Surg 17:656-662, 2003.
25. Eisinger DR, Suranyi MG, Bracs P, Farnsworth A, Sheil AG: Effects of verapamil in the prevention of warm ischaemia induced acute renal failure in dogs. Aust N Z J Surg 55:391-396, 1985.
26. Blardi P, Urso R, De Lalla A, Volpi L, Perri TD, Auteri A: Nimodipine: drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemia. Clin Pharmacol Ther 72:556-561, 2002.
27. Muck W, Breuel HP, Kuhlmann J: The influence of age on the pharmacokinetics of nimodipine. Int J Clin Pharmacol Ther 34:293-298, 1996.
28. Sandin R, Wahlberg J, Modig J: Variations in superficial renal cortical blood flow and tissue oxygenation: an experimental porcine model. Acta Anaesthesiol Scand 35:411-419, 1991.
29. Petoukhova AL, Steebergen W, Morales F, Graaff R, de Jong ED, Elstrodt JM, de Mul FFM, Rakhorst G: Instrument-independent flux units for laser Doppler perfusion monitoring assessed in a multi-device study on the renal cortex. Microvasc Res 66:83-90, 2003.
30. Opie LL: Calcium channel antagonists part III: use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications. Cardiovasc Drugs Ther 1:625-656, 1988.
31. Waldmann KH, Wendt M, Bickhardt K: Kreatinin-Clearance als Grundlage klinischer Nierenfunktionsbestimmung beim Schwein. Tierärtzl Prax 19:373-380, 1991
32. Wendt M, Waldmann KH, Bickhardt K: Vergleichende Untersuchung der Inluinund Creatinin-Clearance beim Schwein. J Vet Med A 37:752-759, 1990.
33. Korenkov AI, Pahnke J, Frei K, Warzok R, Schroeder HW, Frick R, Muljana L, Piek J, Yonekawa Y, Gaab MR: Treatment with nimodipine or mannitol reduces programmed cell death and infarct size following focal cerebral ischemia. Neurosurg Rev 23:145-150, 2000.
34. Sobrado M, Lopez MG, Carceller F, Garcia AG, Roda JM: Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia. Neuroscience 118:107-111, 2003.
35. Megyesi J, Andrade L, Vieira JM Jr, Safirstein RL, Price PM: Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney Int 60:2164-2172, 2001.
36. Li KL, Wang JM, Ding HL, Zhao L, Song RH, Chen L: Effect of p21 on the changes in renal tubular epithelial cells after ischemia/reperfusion injury of kidney. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 17:606-610, 2005.
37. O'Reilly MA: DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair. Am J Physiol Lung Cell Mol Physiol 281:L291-L305, 2001.
38. Basu S, Eriksson M: Oxidative injury and survival during endotoxemia. FEBS Lett 438:159-160, 1998.
39. 2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay. J Chromatogr B Biomed Sci Appl 754:333-343, 2001.
40. 2-isoprostane and changes in redox status during warm renal ischemia-reperfusion. Free Radic Biol Med 36:1034-1042, 2004.